Age, comorbidity, treatment decision and prognosis in lung cancer

Approximately 80-85% of lung cancer subtypes are of non-small cell (NSCLC), two-thirds of which are at advanced stages on diagnosis. An observational study was conducted to analyze the influence of age and comorbidity on choice of treatment and prognosis in advanced NSCLC.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Age and ageing 2008-11, Vol.37 (6), p.715-718
Hauptverfasser:	Blanco, José Antonio Gullón, Toste, Isabel Suárez, Alvarez, Ramón Fernández, Cuadrado, Gemma Rubinos, Gonzalvez, Agustín Medina, Martín, Isidro Jesús González
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Age Factors Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - drug therapy Comorbidity Decision making Drug Therapy Elderly people Female Geriatric Assessment Geriatrics Humans Logistic Models Lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Male Medical prognosis Medical treatment Middle Aged Morbidity Multivariate Analysis Prognosis Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Approximately 80-85% of lung cancer subtypes are of non-small cell (NSCLC), two-thirds of which are at advanced stages on diagnosis. An observational study was conducted to analyze the influence of age and comorbidity on choice of treatment and prognosis in advanced NSCLC.
ISSN:	0002-0729 1468-2834
DOI:	10.1093/ageing/afn226